FibroGen Stock (NASDAQ: FGEN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 2.794M |
Day Range | - - - |
52 Wk Range | 0.333 - 20.900 |
Market Cap | $125.439M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 6.91% |
Days to Cover | 3.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of FibroGen (NASDAQ: FGEN) through any online brokerage.
Other companies in FibroGen’s space includes: Zura Bio (NASDAQ:ZURA), Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), CytomX Therapeutics (NASDAQ:CTMX) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for FibroGen (NASDAQ: FGEN) was reported by B of A Securities on Tuesday, August 8, 2023. The analyst firm set a price target for 2.00 expecting FGEN to rise to within 12 months (a possible 57.48% upside). 8 analyst firms have reported ratings in the last year.
The stock price for FibroGen (NASDAQ: FGEN) is $1.27 last updated April 17, 2024 at 4:00 PM EDT.
There are no upcoming dividends for FibroGen.
FibroGen’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for FibroGen.
FibroGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.